Medscape: Treating obstructive sleep apnea with CPAP therapy protects against myocardial infarction, stroke, and other cardiovascular (CV) events, particularly for patients with moderate to severe OSA and those who are more adherent to CPAP therapy, a new study suggests.
“Most clinical trials on the effect of CPAP on CV diseases to date have focused on secondary CV prevention. This study contributes another piece of evidence about the role of CPAP therapy to prevent CV diseases,” Diego R. Mazzotti, PhD, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, told Medscape Medical News.
“Our study, while observational, suggests that clinical trials focused on understanding how to sustain long-term CPAP adherence in obstructive sleep apnea patients are necessary and could be critical for optimizing comorbidity risk reduction,” Mazzotti said.
The study was presented at the SLEEP 2021: 35th Annual Meeting of the Associated Professional Sleep Societies.
